The medical-device maker beats quarterly earnings expectations but offers a disappointing outlook for the current quarter.

Boston Scientific stock fell 8.4% despite beating Q4 earnings as weak Q1 guidance and electrophysiology division miss ...

Researchers mimicked the air-trapping tricks of diving bell spiders to create aluminum that stays afloat—even when punctured ...

The sun is experiencing a violent solar storm, releasing one of the strongest solar flares seen in the past 30 years ...

Medical device company Boston Scientific (NYSE:BSX) in Q4 CY2025, with sales up 15.9% year on year to $5.29 billion. The ...

I'll be keeping a close eye on Boston Scientific stock following the market's peculiar reaction to its solid earnings report.

Boston Scientific Corporation (NYSE: BSX) reported Q4 2025 revenues of $5.29B, beating management guidance and consensus estimate.

Boston Scientific (BSX) stock drops deespite Q4 2025 earnings beat as the company's Q1 2026 and full-year outlook fails to ...

Q4 2025 earnings call recap: revenue, EPS beat, 2026 organic growth & guidance, key drivers (EP, WATCHMAN) and risks—read now ...

EPFL professor Robert West and invited professor Ágnes Horvát discuss how the rise of AI is transforming the dissemination ...

OpenAI has launched Prism, a revolutionary AI-native workspace for scientists powered by GPT-5.2. Discover how this tool ...